Genomics of acute lung injury. 2006

Carlos Flores, and Shwu-Fan Ma, and Karen Maresso, and Omer Ahmed, and Joe G N Garcia
Department of Medicine, Section of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, Illinois 60637, USA.

Acute lung injury (ALI) is a complex syndrome involving the interplay of both environmental (such as the addition of mechanical ventilation) and genetic factors. Clinical models have identified risk factors for development and poor outcome but these strategies remain imprecise. To better understand the mechanisms of pathogenesis associated with mechanisms of ALI, candidate genes identified by global expression profiling or related literature searches are being explored for relevant polymorphisms (single base pair substitutions) that can affect both ALI susceptibility and outcome. This article summarizes several specific genetic association studies that have been conducted in ALI and reviews supporting data from in vitro and in vivo models of the disease and clinical observations. Although valuable information has been reported to date, intense analyses are needed in this developing discipline to assure significant clinical utility. The detailing of specific associated polymorphisms will continue to provide new insights in the understanding of disease pathogenesis, and promise to reveal novel molecular targets and personalized treatments to prevent the disease.

UI MeSH Term Description Entries
D007703 Peptidyl-Dipeptidase A A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of ANGIOTENSIN I to ANGIOTENSIN II, with increase in vasoconstrictor activity, but no action on angiotensin II. It is also able to inactivate BRADYKININ, a potent vasodilator; and has a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. (From https://www.uniprot.org April 15, 2020). ACE1 Angiotensin-Converting Enzyme 1,ACE1 Protein,Angiotensin Converting Enzyme,Angiotensin Converting Enzyme 1,Antigens, CD143,CD143 Antigens,Dipeptidyl Carboxypeptidase I,Kininase II,Peptidase P,Angiotensin I-Converting Enzyme,Carboxycathepsin,Dipeptidyl Peptidase A,Kininase A,ACE1 Angiotensin Converting Enzyme 1,Angiotensin I Converting Enzyme,Carboxypeptidase I, Dipeptidyl,Peptidyl Dipeptidase A
D012128 Respiratory Distress Syndrome A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA. ARDS, Human,Acute Respiratory Distress Syndrome,Adult Respiratory Distress Syndrome,Pediatric Respiratory Distress Syndrome,Respiratory Distress Syndrome, Acute,Respiratory Distress Syndrome, Adult,Respiratory Distress Syndrome, Pediatric,Shock Lung,Distress Syndrome, Respiratory,Distress Syndromes, Respiratory,Human ARDS,Lung, Shock,Respiratory Distress Syndromes,Syndrome, Respiratory Distress
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D020869 Gene Expression Profiling The determination of the pattern of genes expressed at the level of GENETIC TRANSCRIPTION, under specific circumstances or in a specific cell. Gene Expression Analysis,Gene Expression Pattern Analysis,Transcript Expression Analysis,Transcriptome Profiling,Transcriptomics,mRNA Differential Display,Gene Expression Monitoring,Transcriptome Analysis,Analyses, Gene Expression,Analyses, Transcript Expression,Analyses, Transcriptome,Analysis, Gene Expression,Analysis, Transcript Expression,Analysis, Transcriptome,Differential Display, mRNA,Differential Displays, mRNA,Expression Analyses, Gene,Expression Analysis, Gene,Gene Expression Analyses,Gene Expression Monitorings,Gene Expression Profilings,Monitoring, Gene Expression,Monitorings, Gene Expression,Profiling, Gene Expression,Profiling, Transcriptome,Profilings, Gene Expression,Profilings, Transcriptome,Transcript Expression Analyses,Transcriptome Analyses,Transcriptome Profilings,mRNA Differential Displays
D036341 Intercellular Signaling Peptides and Proteins Regulatory proteins and peptides that are signaling molecules involved in the process of PARACRINE COMMUNICATION. They are generally considered factors that are expressed by one cell and are responded to by receptors on another nearby cell. They are distinguished from HORMONES in that their actions are local rather than distal. Growth Factor,Growth Factors,Paracrine Peptide Factors,Paracrine Protein Factors,Factor, Growth,Factors, Growth,Peptide Factors, Paracrine
D037661 Pulmonary Surfactant-Associated Proteins Proteins found in the LUNG that act as PULMONARY SURFACTANTS. Lung-Surfactant Proteins,PSFAP,Pulmonary Surfactant-Associated Protein,Pulmonary Surfactant-Associated Proteolipid,Lung Surfactant Proteins,Proteins, Lung-Surfactant,Pulmonary Surfactant Associated Protein,Pulmonary Surfactant Associated Proteins,Pulmonary Surfactant Associated Proteolipid,Surfactant-Associated Protein, Pulmonary,Surfactant-Associated Proteins, Pulmonary,Surfactant-Associated Proteolipid, Pulmonary

Related Publications

Carlos Flores, and Shwu-Fan Ma, and Karen Maresso, and Omer Ahmed, and Joe G N Garcia
March 2002, Chest,
Carlos Flores, and Shwu-Fan Ma, and Karen Maresso, and Omer Ahmed, and Joe G N Garcia
July 2010, Proceedings of the American Thoracic Society,
Carlos Flores, and Shwu-Fan Ma, and Karen Maresso, and Omer Ahmed, and Joe G N Garcia
April 2008, Proceedings of the American Thoracic Society,
Carlos Flores, and Shwu-Fan Ma, and Karen Maresso, and Omer Ahmed, and Joe G N Garcia
January 2001, Advances in experimental medicine and biology,
Carlos Flores, and Shwu-Fan Ma, and Karen Maresso, and Omer Ahmed, and Joe G N Garcia
January 2000, Inhalation toxicology,
Carlos Flores, and Shwu-Fan Ma, and Karen Maresso, and Omer Ahmed, and Joe G N Garcia
February 2008, Current opinion in critical care,
Carlos Flores, and Shwu-Fan Ma, and Karen Maresso, and Omer Ahmed, and Joe G N Garcia
November 2003, American journal of respiratory and critical care medicine,
Carlos Flores, and Shwu-Fan Ma, and Karen Maresso, and Omer Ahmed, and Joe G N Garcia
July 1986, Critical care clinics,
Carlos Flores, and Shwu-Fan Ma, and Karen Maresso, and Omer Ahmed, and Joe G N Garcia
May 2020, Current problems in surgery,
Carlos Flores, and Shwu-Fan Ma, and Karen Maresso, and Omer Ahmed, and Joe G N Garcia
August 2013, Seminars in respiratory and critical care medicine,
Copied contents to your clipboard!